We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$111B
AUM Growth
+$10.5B
(+10%)
Cap. Flow
+$4.07B
Cap. Flow
% of AUM
3.67%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
4,333
New
263
Increased
1,254
Reduced
2,016
Closed
548
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$754M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$743M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$526M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$384M |
| 5 |
British American Tobacco
BTI
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$308M |
| 2 |
AGN
Allergan plc
AGN
|
+$233M |
| 3 |
BATS
Bats Global Markets, Inc.
BATS
|
+$190M |
| 4 |
ACAS
American Capital Ltd
ACAS
|
+$186M |
| 5 |
SLB Ltd
SLB
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.15% |
| 2 | Technology | 9.78% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 6.76% |
| 5 | Consumer Staples | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
SandRidge Energy
SD
$503M
| $257K | ﹤0.01% |
13,930
-14,406
| -51% | -$286K |
|
3377
The Bancorp
TBBK
$2.81B
| $257K | ﹤0.01% |
50,389
-1,911
| -4% | -$10.9K |
|
3378
iShares MSCI India ETF
INDA
$6.81B
| $255K | ﹤0.01% |
8,087
-37,904
| -82% | -$1.11M |
|
3379
Citizens
CIA
$248M
| $254K | ﹤0.01% |
34,170
-13,517
| -28% | -$120K |
|
3380
Kinsale Capital Group
KNSL
$8.58B
| $252K | ﹤0.01% |
7,886
-4,001
| -34% | -$124K |
|
|
GRP.U
3381
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $250K | ﹤0.01% |
+7,160
| New | +$244K |
|
3382
Applied Optoelectronics
AAOI
$6.14B
| $247K | ﹤0.01% |
4,401
-9,397
| -68% | -$371K |
|
|
CPL
3383
DELISTED
CPFL Energia S.A.
CPL
| $247K | ﹤0.01% |
15,016
-62,113
| -81% | -$1.01M |
|
|
BT
3384
DELISTED
BT Group plc (ADR)
BT
| $247K | ﹤0.01% |
12,313
-21,959
| -64% | -$460K |
|
3385
Hovnanian Enterprises
HOV
$779M
| $246K | ﹤0.01% |
4,333
-835
| -16% | -$49.3K |
|
3386
Park-Ohio Holdings
PKOH
$550M
| $246K | ﹤0.01% |
6,845
-802
| -10% | -$33.1K |
|
3387
Johnson Outdoors
JOUT
$496M
| $245K | ﹤0.01% |
6,711
+586
| +10% | +$20.5K |
|
3388
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
| $243K | ﹤0.01% |
2,000
-67,531
| -97% | -$8.09M |
|
3389
MakeMyTrip
MMYT
$5.38B
| $242K | ﹤0.01% |
+7,000
| New | +$225K |
|
|
RFP
3390
DELISTED
Resolute Forest Products Inc.
RFP
| $242K | ﹤0.01% |
44,563
+2,908
| +7% | +$14.4K |
|
|
KEM
3391
DELISTED
KEMET Corporation
KEM
| $240K | ﹤0.01% |
19,995
-93,175
| -82% | -$844K |
|
3392
Bank of America Series L
BAC.PRL
$3.93B
| $239K | ﹤0.01% |
+200
| New | +$238K |
|
3393
Barings BDC
BBDC
$869M
| $239K | ﹤0.01% |
+12,502
| New | +$240K |
|
3394
iShares MSCI ACWI ETF
ACWI
$32B
| $237K | ﹤0.01% |
3,737
-20,337
| -84% | -$1.26M |
|
|
KDNY
3395
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $237K | ﹤0.01% |
4,417
-1,169
| -21% | -$66K |
|
3396
RELX
RELX
$66.7B
| $235K | ﹤0.01% |
11,836
+1,198
| +11% | +$22.4K |
|
|
SIOX
3397
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $235K | ﹤0.01% |
1,967
-2,550
| -56% | -$267K |
|
3398
Anavex Life Sciences
AVXL
$231M
| $233K | ﹤0.01% |
40,492
-8,512
| -17% | -$44K |
|
|
NVLN
3399
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $233K | ﹤0.01% |
21,660
-6,726
| -24% | -$68.7K |
|
3400
Live Oak Bancshares
LOB
$1.98B
| $231K | ﹤0.01% |
10,677
+207
| +2% | +$4.39K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2017 Portfolio in Review
As of Q1 2017, Credit Suisse held 4,333 positions worth $111B, up 10% from $100B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse deployed $4.07B of net new capital in Q1 2017, opening 263 new positions and adding to 1,254 existing holdings. Its largest new stake was Qiagen: 1,270,687 shares worth $39M.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Cognizant, an estimated $308M trimmed.
- Credit Suisse's largest Q1 2017 buy was Qiagen: 1,270,687 shares worth $39M.
- Credit Suisse added most to Reynolds American Inc in Q1 2017, an estimated $754M increase.
- Credit Suisse's biggest Q1 2017 reduction was Cognizant, cutting an estimated $308M.
- Credit Suisse fully exited Bats Global Markets, Inc. in Q1 2017, selling an estimated $190M.
- Credit Suisse's ten largest holdings make up 17% of its $111B portfolio in Q1 2017.
- Credit Suisse opened 263 new positions and closed 548 in Q1 2017.
- Credit Suisse's portfolio value rose 10% quarter-over-quarter to $111B.
Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.